In the realm of global auto manufacturing, China’s influence stretches far beyond its borders. Recent financial reports from industry giants……
Nvidia’s Denial of China AI Chip Rollout Sparks Discussion on Market Strategy
Nvidia has rejected recent reports regarding the launch of a China-specific language processing unit (LPU) by the end of the……
Trade Friction Eases: China and Switzerland Establish Tariff-Free Agreement
In a significant move aimed at fostering closer economic ties, China and Switzerland have reached a momentous accord to eliminate……
Estee Lauder Readies for Profit Surge with China Strategy
Estee Lauder anticipates strong annual profit growth, outperforming Wall Street expectations. The company’s CEO-led turnaround initiative aims to fuel demand……
China’s Advancements in Robotics: A Closer Look at Technological Innovations in China and the US
China’s robotics industry is making significant strides in the field, showcasing innovative robots in various cities in China.
Unitree’s latest creation,…
China's Advancements in Robotics: A Closer Look at Technological Innovations in China and ……
China’s Robotics Industry Surges Ahead in Global Market Dominance
China’s prowess in the robotics industry has recently come into the spotlight with groundbreaking developments showcasing a potential lead over……
Switzerland and China Forge Stronger Trade Ties in Historic Agreement
Switzerland and China have embarked on a new era of duty-free trade following the announcement of an upgraded free trade……
China’s Diverse Energy Strategy: A Look at Fossil Fuels and Renewables
China’s pursuit of energy self-sufficiency is taking a multifaceted approach involving both fossil fuels and renewables. In 2025, China set……
The Rise of Pakistani Donkeys in Global Trade and China’s Demand for Donkey Hides
In the realm of international trade, a humble animal from Pakistan – the donkey – has unexpectedly found itself at……
Di Zhe Pharmaceuticals Reports Revenue Surpassing $500 Million in First Half, Advances Globalization Strategy into Innovation Value Realization Phase
Di Zhe Pharmaceuticals (stock code: 688192.SH) announced its 2026 interim report on August 20, 2026, revealing a revenue of $523……
-
-
Recent Updates
- China-Market Brief: Univest Securities Completes $1.2 Million Offering for Nasdaq-Listed JIADE
- Atlas Copco and Ansteel Deepen China Steel Partnership at Import Expo
- China’s Insulin Procurement Policy Slashed Drug Costs Nearly Half in Shanghai Hospitals
- Shanghai Precision Diagnostics and Fudan University Shanghai Cancer Center Launch Breast Cancer Biomarker Study Using 10x Genomics’ Xenium Platform
- China Europe Innovation Dialogue in Shanghai Highlights Push for Technology Ties
- Novo Nordisk Wins China Patent Extension for Ozempic Kidney Disease Use
- China 3D Printer Maker Raise3D Fuzhi Technology Raises 100 Million Yuan and Unveils Large Format Machines
- Saudi Arabia Probes China and Turkey Steel Imports After Dumping Complaint
- Nvidia and Jensen Huang Face Suit over Alleged China Spy Affair
- Nvidia Scrutinizes China Spying Claims as Singapore Chip Links Draw Attention
Blogroll